Perrigo Co. Plc engages in the provision of self-care products and over the counter health and wellness solutions. It enhances individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. It operates through the Consumer Self-Care Americas and Consumer Self-Care International segments. The Consumer Self-Care Americas segment offers OTC solutions, infant formula, oral care, and contract manufacturing in the U.S, Mexico, and Canada. The Consumer Self-Care International segment includes the self-care business branded in Europe, Australia, the United Kingdom, and parts of Europe and Asia. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Andersen Svend | EVP & President CHCI | Mar 07 '24 | Option Exercise | 29.69 | 5,468 | 162,345 | 100,853 | Mar 08 07:18 PM | Janish Ronald Craig | EVP, Gbl Ops & SC & CTO | Mar 07 '24 | Option Exercise | 29.69 | 2,942 | 87,348 | 34,439 | Mar 08 09:18 PM | Quinn Grainne | EVP, Chief Medical Officer | Mar 07 '24 | Option Exercise | 29.69 | 2,249 | 66,773 | 22,248 | Mar 08 09:57 PM | Willis Robert | EVP & CHRO | Mar 07 '24 | Option Exercise | 29.69 | 2,163 | 64,219 | 32,595 | Mar 08 09:34 PM | Ives Alison | EVP & Chief Scientific Officer | Mar 07 '24 | Option Exercise | 29.69 | 1,746 | 51,839 | 18,536 | Mar 08 07:36 PM | Bezerra Eduardo Guarita | EVP & Chief Financial Officer | Mar 06 '24 | Option Exercise | 28.09 | 4,870 | 136,798 | 13,298 | Mar 08 07:51 PM | Andersen Svend | EVP & President CHCI | Mar 06 '24 | Option Exercise | 28.09 | 3,788 | 106,405 | 95,385 | Mar 08 07:18 PM | HANSON KYLE | EVP & General Counsel | Mar 06 '24 | Option Exercise | 28.09 | 3,518 | 98,821 | 12,284 | Mar 08 08:52 PM | Janish Ronald Craig | EVP, Gbl Ops & SC & CTO | Mar 06 '24 | Option Exercise | 28.09 | 2,300 | 64,607 | 32,190 | Mar 08 09:18 PM | Ives Alison | EVP & Chief Scientific Officer | Mar 06 '24 | Option Exercise | 28.09 | 2,030 | 57,023 | 17,402 | Mar 08 07:36 PM | Farrington Thomas | EVP and CIO | Mar 06 '24 | Option Exercise | 28.09 | 1,881 | 52,837 | 11,389 | Mar 08 08:17 PM | Quinn Grainne | EVP, Chief Medical Officer | Mar 06 '24 | Option Exercise | 28.09 | 1,759 | 49,410 | 20,914 | Mar 08 09:57 PM | Willis Robert | EVP & CHRO | Mar 06 '24 | Option Exercise | 28.09 | 1,759 | 49,410 | 31,347 | Mar 08 09:34 PM | Andersen Svend | EVP & President CHCI | Mar 05 '24 | Option Exercise | 27.26 | 3,411 | 92,984 | 72,152 | Mar 07 08:31 PM | Janish Ronald Craig | EVP, Gbl Ops & SC & CTO | Mar 05 '24 | Option Exercise | 27.26 | 2,071 | 56,455 | 22,262 | Mar 07 09:28 PM | Ives Alison | EVP & Chief Scientific Officer | Mar 05 '24 | Option Exercise | 27.26 | 1,698 | 46,287 | 14,144 | Mar 07 09:58 PM | Farrington Thomas | EVP and CIO | Mar 05 '24 | Option Exercise | 27.26 | 1,693 | 46,151 | 4,516 | Mar 07 08:49 PM | Quinn Grainne | EVP, Chief Medical Officer | Mar 05 '24 | Option Exercise | 27.26 | 1,583 | 43,153 | 15,646 | Mar 07 09:00 PM | Willis Robert | EVP & CHRO | Mar 05 '24 | Option Exercise | 27.26 | 1,279 | 34,866 | 26,755 | Mar 07 09:10 PM | Ives Alison | EVP & Chief Scientific Officer | Mar 05 '24 | Buy | 27.26 | 2,490 | 67,877 | 16,122 | Mar 07 09:58 PM | Willis Robert | EVP & CHRO | Mar 01 '24 | Buy | 26.30 | 371 | 9,757 | 25,476 | Mar 01 02:31 PM | Lockwood-Taylor Patrick | CEO | Feb 29 '24 | Buy | 26.54 | 9,500 | 252,168 | 20,500 | Feb 29 01:39 PM | Willis Robert | EVP & CHRO | Feb 29 '24 | Buy | 25.87 | 6,000 | 155,220 | 25,105 | Mar 01 02:31 PM | Ives Alison | EVP & Chief Scientific Officer | Feb 29 '24 | Buy | 26.44 | 1,545 | 40,850 | 12,446 | Mar 07 09:54 PM | Willis Robert | EVP & CHRO | Nov 24 '23 | Buy | 31.01 | 5,550 | 172,106 | 19,105 | Nov 27 07:12 PM | Ives Alison | EVP & Chief Scientific Officer | Nov 16 '23 | Buy | 29.34 | 2,040 | 59,854 | 10,380 | Nov 17 06:03 AM | Lockwood-Taylor Patrick | CEO | Nov 14 '23 | Buy | 28.99 | 11,000 | 318,868 | 11,000 | Nov 14 07:12 PM | Bezerra Eduardo Guarita | EVP & Chief Financial Officer | Nov 14 '23 | Buy | 29.18 | 5,000 | 145,882 | 8,428 | Nov 15 12:14 PM | Ives Alison | EVP & Chief Scientific Officer | Oct 06 '23 | Option Exercise | 30.46 | 738 | 22,479 | 9,078 | Oct 10 08:23 AM | Manzone Albert | Director | Aug 15 '23 | Option Exercise | 38.88 | 5,478 | 212,985 | 5,478 | Aug 17 12:48 PM | HANSON KYLE | EVP & General Counsel | Jul 07 '23 | Option Exercise | 32.63 | 12,409 | 404,906 | 9,732 | Jul 10 01:17 PM | Ives Alison | EVP & Chief Scientific Officer | Jul 07 '23 | Option Exercise | 32.63 | 920 | 30,020 | 8,611 | Jul 10 01:18 PM | Parker Geoffrey M. | Director | Jun 13 '23 | Buy | 33.06 | 10,000 | 330,637 | 25,879 | Jun 14 10:54 AM | Bezerra Eduardo Guarita | EVP & Chief Financial Officer | Jun 07 '23 | Option Exercise | 33.72 | 4,532 | 152,819 | 4,532 | Jun 09 09:38 AM | Andersen Svend | EVP & President CHCI | May 23 '23 | Buy | 33.41 | 2,900 | 96,902 | 68,741 | May 25 08:16 AM | ASHFORD ORLANDO D | Director | May 17 '23 | Option Exercise | 32.86 | 9,723 | 319,498 | 14,705 | May 19 02:39 PM | KINDLER JEFFREY B | Director | May 17 '23 | Option Exercise | 32.86 | 7,778 | 255,585 | 22,184 | May 19 02:39 PM | Doyle Katherine C. | Director | May 17 '23 | Option Exercise | 32.86 | 7,778 | 255,585 | 14,140 | May 19 02:39 PM | Parker Geoffrey M. | Director | May 17 '23 | Option Exercise | 32.86 | 7,778 | 255,585 | 19,439 | May 19 02:38 PM | O'Connor Donal | Director | May 17 '23 | Option Exercise | 32.86 | 7,778 | 255,585 | 24,664 | May 19 02:38 PM | Mann Erica L | Director | May 17 '23 | Option Exercise | 32.86 | 7,778 | 255,585 | 16,635 | May 19 02:37 PM | Alford Bradley A | Director | May 17 '23 | Option Exercise | 32.86 | 7,778 | 255,585 | 35,187 | May 19 02:37 PM | Karaboutis Adriana | Director | May 17 '23 | Option Exercise | 32.86 | 7,778 | 255,585 | 21,656 | May 19 02:38 PM |
|